Skip to content

Zevra Therapeutics, Inc. ZVRA Investment Purchases

Investment Purchases at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$25.79M-71.1%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$131M
Theravance Biopharma logo
Theravance BiopharmaTBPH
$43.41M+2,106%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$50.9M+132%
Arrowhead Research logo
Arrowhead ResearchARWR
$924.64M+43.5%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$52.67M

Other financials

Income statement

See full
Revenue$36.2M+77.5%
Gross profit$34.3M+80.1%
Operating income$52.1M+1,073%
Net income$37.9M+1,323%
EPS (diluted)$0.60+1,100%

Balance sheet

See full
Cash & equivalents$95.6M+156%
Total debt$1.1M-98.1%
Total equity$205.8M+402%
Total assets$278.6M+61.3%

Cash flow

See full
Operating cash flow$6.1M+175%
CapEx$35.0K-64.6%
Free cash flow$6.1M+173%

Valuation

See full
Market cap$782.09M+58.2%
Enterprise value$687.64M+32.5%
P/E6.3×
P/S6.4×-5.8×

Profitability

See full
Gross margin86.1%+7.2pp
Operating margin-103.9%-43.0pp
Net margin101.6%+60.1pp
FCF margin-75%-30.5pp

Returns & leverage

See full
Return on equity100.7%+60.3pp
Debt / equity-1.5×
Current ratio4.9×+1.9×

Where this comes from

Reported directly by Zevra Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireOtherInvestments.

The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zevra Therapeutics, Inc.'s investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zevra Therapeutics, Inc.'s investment purchases?
Zevra Therapeutics, Inc. (ZVRA) reported investment purchases of $58.3M in Q1 2026.
How has Zevra Therapeutics, Inc.'s investment purchases changed year-over-year?
Zevra Therapeutics, Inc.'s investment purchases increased by 692.2% year-over-year, from $7.36M to $58.3M.
What is the long-term trend for Zevra Therapeutics, Inc.'s investment purchases?
Over 4 years (2021 to 2025), Zevra Therapeutics, Inc.'s investment purchases has grown at a 111.7% compound annual growth rate (CAGR), from $15.42M to $309.99M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.